Author:
Tuan Din Sharifah Azdiana,Mohd Sopian Mastura,Ahmad Tajuddin Nur Dalila Nabihan,Abdullah Azrul
Abstract
Introduction: ABO blood group can be associated with chronic diseases, for example, cancer and coronary heart disease, however it is not proven in Type 2 Diabetes Mellitus (T2DM). The aim of this study was to identify the association between the ABO blood group and disease control among T2DM patients at Kepala Batas, Penang. Methods: Approximately two mL vials of fresh blood were collected and typed using the tube method from 129 T2DM and 132 non-diabetic (control) patients, who visited the specialist clinic. The sociodemographic characteristics of the T2DM patients was analysed using descriptive analysis. The proportions of A, B, AB, and O blood groups among the diabetic and control patients were compared using the chi-square test. Any association between the ABO blood group and disease control was identified using the bivariate correlation test. Results: No significant association was found between the ABO group and T2DM patients (p = 0.152) when compared with the control group. However, blood group B was the most frequent among T2DM patients (33.3%) compared to blood group O within the control group (36.4%). Negative associations were observed between the ABO blood group and BMI (r = 0.098, p = 0.268), as well as the HbA1C value (r = -0.065, p = 0.464). Conclusion: No association was found between the ABO blood group and the associated risk factors (BMI and HbA1C). However, individuals with blood group B and risk factors, such as older age group, obesity, and high HbA1C value (more than 7.0%), should be monitored.
Publisher
Universiti Putra Malaysia
Reference18 articles.
1. 1. IDF (2017) Eighth edition 2017. 8th edn. Edited by K. Suvi et al.
2. 2. Institute for Public Health (IPH). The Fourth National Health and Morbidity Survey (NHMS IV) 2011. Vol. II: Non-Communicable Diseases. National Diabetes Registry Report Volume 1, 2009e2012. Putrajaya, Malaysia: IPH; 2012
3. 3. Mafauzy, M., Hussein, Z. and Chan, S. P. (2011) The Status of Diabetes Control in Malaysia: Results of Diabcare 2008. Medical Journal of Malaysia, 66(3), p. 175–181.
4. 4. Hussein, Z., Taher, S. W., Singh, H. K. G. and Swee, W. C. S. (2015) Diabetes Care in Malaysia: Problems, New Models, and Solutions. Annals of Global Health. Elsevier Inc, 81(6), p. 851–862. doi: 10.1016/j.aogh.2015.12.016
5. 5. Franchini, M., Favaloro, E. J., Targher, G. and Lippi, G. (2012) ABO blood group, hypercoagulability and cardiovascular and cancer risk. Critical Reviews in Clinical Laboratory Sciences, 49(4), p. 137–149. doi: 10.3109/10408363.2012.708647